Despite the battery of support measures announced by the ECB the day before, the European stock markets fell (-0.6% in London, -0.8% in Frankfurt, -0.7% in Paris) against a backdrop of difficulties in the negotiations between London and Brussels.

"The Frankfurt institution has announced that its asset purchase program has been extended by nine months, until at least March 2022, and has increased its ceiling by 500 billion euros to bring it to 1.850 billion", recalls Kiplink.

The latter notes, however, that investors are worried about future trade relations between the United Kingdom and the European Union after December 31, the two camps evoking more and more clearly the hypothesis of a "no deal".

"They still have until Sunday to find common ground on European access to British waters, the procedures for settling future disputes and the guarantees required by Brussels from London in terms of competition", continues- he.

On the values front, Zurich Insurance yielded nearly 2% on the SMI, after the announcement by the insurance company that its American subsidiary Farmers Group will acquire the damage insurance activity of MetLife in the United States.

Sanofi fell 2% in Paris, but GSK grabbed almost 1% in London, as the two health groups announced that the conduct of their vaccine program against Covid-19 is delayed in order to improve the immune response in old people.